This paper is in the following e-collection/theme issue:

Cancer Epidemiology, Cancer Surveillance and Infodemiology (77) Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1641) Infoveillance, Infodemiology, Digital Disease Surveillance, Infodemic Management (1041) Infodemiology and Infoveillance (1349)

Published on in Vol 8, No 2 (2022): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/34073, first published .
The Experiences of Patients With Adjuvant and Metastatic Melanoma Using Disease-Specific Social Media Communities in the Advent of Novel Therapies (Excite Project): Social Media Listening Study

The Experiences of Patients With Adjuvant and Metastatic Melanoma Using Disease-Specific Social Media Communities in the Advent of Novel Therapies (Excite Project): Social Media Listening Study

The Experiences of Patients With Adjuvant and Metastatic Melanoma Using Disease-Specific Social Media Communities in the Advent of Novel Therapies (Excite Project): Social Media Listening Study

Authors of this article:

Guy Faust1 Author Orcid Image ;   Alison Booth2 Author Orcid Image ;   Evie Merinopoulou2 Author Orcid Image ;   Sonia Halhol2 Author Orcid Image ;   Heena Tosar3 Author Orcid Image ;   Amir Nawaz3 Author Orcid Image ;   Magdalena Szlachetka3 Author Orcid Image ;   Gavin Chiu3 Author Orcid Image
Article Authors Cited by (4) Tweetations (4) Metrics

Guy Faust   1 , MD ;   Alison Booth   2 , BSc, MSc ;   Evie Merinopoulou   2 , MSc ;   Sonia Halhol   2 , BSc, MSc ;   Heena Tosar   3 , BSc ;   Amir Nawaz   3 , MPharm ;   Magdalena Szlachetka   3 , MPharm ;   Gavin Chiu   3 , BSc, MRCGP, MBBS

1 University Hospitals of Leicester National Health Service Trust, Leicester, United Kingdom

2 Evidera, London, United Kingdom

3 Novartis, London, United Kingdom

Corresponding Author: